News: Infinx acquires Glidian to expand AI-driven prior authorization solutions, improving patient access and streamlining ...
Sarepta Therapeutics shares dropped 20% after a patient's death raises Elevidys safety concerns. Read why I am downgrading ...
FDA grants fast track designation to azer-cel, an allogeneic CAR T-cell therapy, for relapsed or refractory diffuse large ...
Q4 2024 Earnings Call Transcript March 20, 2025 Abeona Therapeutics Inc. beats earnings expectations. Reported EPS is $-0.24, ...
The Minns Labor Government has awarded funding to a Newcastle-based researcher focussed on improving outcomes for regional and rural cancer patients ...
China approved 48 first-in-class innovative drugs, as well as a significant number of medications for pediatric and rare ...
This accelerated pathway for new drugs and therapies ... Intelligence and learnings from the delivery of the early and managed patient access schemes will be used to better understand impact ...
It’s not clear how many other pediatric cancer patients are currently waiting for access to the drug in Canada and the ...
SAN JOSE, Calif., March 18, 2025 /PRNewswire/ -- At NVIDIA GTC 2025, ThisWay Global is unveiling how it enabled Humanate Digital to transform years of fragmented research into actionable intelligence ...
REGENXBIO (RGNX) reported new, positive interim data from two additional patients in the Phase I/II portion of the AFFINITY DUCHENNE trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback